120. 遺伝性ジストニア Hereditary dystonia Clinical trials / Disease details
臨床試験数 : 25 / 薬物数 : 21 - (DrugBank : 4) / 標的遺伝子数 : 2 - 標的パスウェイ数 : 2
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04182763 (ClinicalTrials.gov) | December 4, 2019 | 24/11/2019 | CoA-Z in Pantothenate Kinase-associated Neurodegeneration (PKAN) | A Phase 2 Study of a Vitamin Metabolite for PKAN | Pantothenate Kinase-Associated Neurodegeneration | Other: CoA-Z;Other: Placebo | Oregon Health and Science University | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);Washington State University;Oregon State University;Spoonbill Foundation | Recruiting | 3 Months | 89 Years | All | 51 | Phase 2 | United States |